Inventor · disambiguated record
Per A. Peterson
Also filed as: PETERSON PER · PETERSON PER A · PETERSON PER ANDERS
36 granted patents·11 pending applications·694 citations·filing 1992–2023
98Inventor score
Files withSCRIPPS RESEARCH INST18CAI ZELING6ORTHO MCNEIL PHARM INC6LUDWIG INST CANCER RES2ORTHO PHARMA CORP2
Top patents by PatentIndex Score
47 records- 0194US7842501B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseORTHO MCNEIL PHARM INC·Filed 2007·Granted Nov 30, 2010·25 cites·1 claims
- 0293US6355479B1MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 1997·Granted Mar 12, 2002·98 cites·36 claims
- 0392US6255073B1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 1998·Granted Jul 3, 2001·79 cites·4 claims
- 0490US8084256B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Dec 27, 2011·10 cites·1 claims
- 0588US7993638B2Cancer treatment combining lymphodepleting agent with CTLs and cytokinesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 9, 2011·13 cites·7 claims
- 0688US6828150B2Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 2002·Granted Dec 7, 2004·11 cites·10 claims
- 0788US5529921AIn vitro activation of cytotoxic t-cells using insect cells expressing human class I MHC and β2-microglobulinSCRIPPS RESEARCH INST·Filed 1994·Granted Jun 25, 1996·56 cites·12 claims
- 0888US5314813ADrosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell linesSCRIPPS RESEARCH INST·Filed 1992·Granted May 24, 1994·59 cites·9 claims
- 0987US6225042B1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 1998·Granted May 1, 2001·55 cites·5 claims
- 1085US6372955B1Methods for Producing B cells and antibodies from H2-O modified transgenic miceORTHO MCNEIL PHARM INC·Filed 2000·Granted Apr 16, 2002·23 cites·2 claims
- 1184US7125964B2Purification of antigen-specific T cellsORTHO MCNEIL PHARM INC·Filed 2004·Granted Oct 24, 2006·15 cites·3 claims
- 1283US6362001B1Method for producing a synthetic antigen presenting transformed Drosophila cellSCRIPPS RESEARCH INST·Filed 1998·Granted Mar 26, 2002·45 cites·2 claims
- 1380US6001365AIn vitro activation of cytotoxic T cellsSCRIPPS RESEARCH INST·Filed 1998·Granted Dec 14, 1999·48 cites·1 claims
- 1480US5827737AIn vitro activation of cytotoxic T cellsSCRIPPS RESEARCH INST·Filed 1996·Granted Oct 27, 1998·39 cites·1 claims
- 1578US8888054B1Secured bag forming and support apparatusPETERSON PER ANDERS·Filed 2011·Granted Nov 18, 2014·12 cites·10 claims
- 1675US6461867B1Synthetic antigen presenting matrixSCRIPPS RESEARCH INST·Filed 1996·Granted Oct 8, 2002·22 cites·3 claims
- 1775US6107476ANucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growthORTHO MCNEIL PHARM INC·Filed 1997·Granted Aug 22, 2000·24 cites·1 claims
- 1874US9222070B2Cell therapy method for the treatment of tumorsLETURCQ DIDIER J·Filed 2007·Granted Dec 29, 2015·1 cites·8 claims
- 1971US11741430B1Integrated priorities and activities alignment, coordination and visualization systems and methodsTHE PETERGREN GROUP LLC·Filed 2020·Granted Aug 29, 2023·1 cites·20 claims
- 2067US6002066AH2-M modified transgenic miceORTHO PHARMA CORP·Filed 1997·Granted Dec 14, 1999·25 cites·8 claims
- 2167US2005152916A1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 2004·Application pending·0 cites
- 2264US7402430B2MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 2004·Granted Jul 22, 2008·1 cites·11 claims
- 2364US7074617B1MHC class II antigen-presenting systems and methods for activatind CD4+T cellsSCRIPPS RESEARCH INST·Filed 2000·Granted Jul 11, 2006·1 cites·24 claims
- 2462US2007098734A1Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseORTHO MCNEIL PHARMACEUTICAL CO·Filed 2006·Application pending·0 cites
- 2561US9222071B2Cell therapy method for the treatment of tumorsMORIARTY ANN·Filed 2008·Granted Dec 29, 2015·0 cites·11 claims
- 2660US2003072796A1Synthetic antigen presenting matrix with liposome supportSCRIPPS RESEARCH INST·Filed 2002·Application pending·0 cites
- 2760US2003077318A1Synthetic antigen presenting matrixSCRIPPS RESEARCH INST·Filed 2002·Application pending·0 cites
- 2860US2024086842A1Integrated priorities and activities alignment, coordination and visualization systems and methodsTHE PETERGREN GROUP LLC·Filed 2023·Application pending·0 cites
- 2959US8133728B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 3059US8133726B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 3159US8133972B2IgE antigenic peptidesCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 3259US8084253B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Dec 27, 2011·0 cites·1 claims
- 3359US2006134125A1Purification of antigen-specific T cellsORTHO PHARMA CORP·Filed 2005·Application pending·0 cites
- 3458US8106153B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Jan 31, 2012·0 cites·1 claims
- 3557US7439335B2MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 2004·Granted Oct 21, 2008·0 cites·22 claims
- 3655US2004071671A1Cell therapy method for the treatment of tumorsFiled 2002·Application pending·0 cites
- 3754US6251627B1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 1998·Granted Jun 26, 2001·5 cites·5 claims
- 3854US2003077708A1Antigen presenting system and methods for activation of T-cellsSCRIPPS RESEARCH INST·Filed 2002·Application pending·0 cites
- 3952US5573939ADNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cellsLUDWIG INST CANCER RES·Filed 1994·Granted Nov 12, 1996·13 cites·10 claims
- 4050US2003077248A1Cell therapy method for the treatment of tumorsFiled 2002·Application pending·0 cites
- 4149US7811816B2Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cellORTHO MCNEIL PHARMAEUTICAL INC·Filed 2002·Granted Oct 12, 2010·0 cites·1 claims
- 4245US2003159166A1H2-O modified transgenic animalsFiled 2002·Application pending·0 cites
- 4345US2003046715A1H2-O modified transgenic animalsFiled 2002·Application pending·0 cites
- 4433US5679772AMammalian retinol-binding protein receptorsLUDWIG INST CANCER RES·Filed 1995·Granted Oct 21, 1997·1 cites·4 claims
- 4532US6225525B1ATP-binding cassette transporter (ABC1) modified transgenic miceORTHO MCNEIL PHARM INC·Filed 1999·Granted May 1, 2001·7 cites·6 claims
- 4627US6166289AIRAK modified transgenic animalsORTHO MCNEIL PHARMACUETICALS·Filed 1999·Granted Dec 26, 2000·5 cites·6 claims
- 4721US6204432B1PA28 modified transgenic miceORTHO MCNEIL PHARM INC·Filed 1999·Granted Mar 20, 2001·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Per A. Peterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →